124. 皮質下梗塞と白質脳症を伴う常染色体優性脳動脈症
[臨床試験数:11,薬物数:13(DrugBank:4),標的遺伝子数:3,標的パスウェイ数:11]
Searched query = "Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy", "CADASIL", "Autosomal dominant cerebral artery disease with subcortical infarct and leukoencephalopathy", "Autosomal dominant cerebral artery disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01361763 (ClinicalTrials.gov) | June 2011 | 16/5/2011 | Safety Study of Dabigatran in CADASIL | Phase II, Randomized, Crossover, Single Blind, Safety Trial of DABIGATRAN Versus ASA for Preventing Ischaemic Brain Lesions in Patients Affected by CADASIL | CADASIL | Drug: Dabigatran;Drug: Antiplatelets | S. Andrea Hospital | NULL | Recruiting | 18 Years | N/A | Both | 50 | Phase 2 | Italy |